Online Submissions

Already have a Username/Password for Ateroscleroz?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines

1. General

In preparing the manuscript, authors are kindly requested to adhere to the following regulations based on the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”, developed by the International Committee of Medical Journal Editors:

The Journal "Ateroscleroz" is a peer-reviewed academic periodical published in Russian.

The Journal publishes original research papers and reviews dedicated to basic issues in the study of atherosclerosis and related diseases. The scientific concept of the journal involves the publication of modern achievements in the diagnosis, treatment and prevention of atherosclerosis, the results of national and international clinical and epidemiological studies.

The Journal is included in the list of scientific publications where key research results in candidacy for Candidate and Doctor's degrees should be published (Higher Attestation Commision's List), effective since December 1, 2015.

No fee is charged for publication.

Manuscripts are not returned.

2. Provision for manuscript publications

2.1. The article submitted should be original and important. The study should be performed by up-to-date methods. It should follow the Ethical Principles for Medical Research Involving Humans and the Rules of Clinical Practice in the Russian Federation. Research demanding the use of experimental animals should be conducted in compliance with the humanity principles proclaimed in the European Communities Council Directive 86/609/ЕЕС and the Helsinki Declaration on Humane Treatment of Animals. Review articles should describe the search strategy with the indication of multidisciplinary and special-purpose databases used.

2.2. The research results should be assessed by valid statistical methods.

2.3. The manuscript should be formatted according to this Guide. Prior to submitting an article for review, please ensure that the files contain all the necessary information in Russian and English, the sources of information are indicated and all citations have been correctly formatted.

2.4. The submission of an article to the journal “Ateroscleroz” implies that:

- the article has not been previously published in another journal;

- the article is not pending publication in another journal;

- all co-authors agree with the publication of the present version of the article.

2.5. The manuscript should be supplemented with a cover letter from the institution where the study was performed. The letter should be signed by the institution head and certified by the common seal. A digital version of the cover letter in the *.pdf or *.jpg format should be uploaded together with the manuscript submitted to the Journal.

3. Manuscript

The manuscript size, without including tables and images, should be limited to 15 pages for experimental and clinical papers, an editorial, 30 pages for literature reviews. The minimum size of the article is three thousand words.

Body text format:

- basic font: Times New Roman, 12 pt;

- spacing: 1.5;

- all margins: 20 mm.

The main components of the manuscript of the article are as follows:

1) the title page and information about the authors in Russian and English;

2) a summary in Russian and English;

3) introduction;

4) material and methods;

5) results;

6) discussion;

7) conclusions;

8) supplementary information in Russian and English;

9) list of used literature.

3.1. Title page

It should contain:

- the title of the article (in Russian and English);

- information about the authors (in Russian and English) - full name, position, title, academic degree, full name of the institution and department (laboratory) in which the work was performed, e-mail, ORCID ID.  

In Russian, when specifying the authors of the article on the title page, the initials should be indicated preceding the surname.

In English, when specifying the authors of the article, the format “First name, Patronymic Initial, Surname” (Ivan I. Ivanov) should be used. Surnames in English should be indicated in accordance with a foreign passport or as was indicated in previously published articles. If the author does not have a foreign passport and / or publications, transliteration of the first name and surname should be done according to the BSI standard.

Authors should indicate all the workplaces relevant to the study. If authors from different institutions took part in the preparation of the article, the affiliation of each author to the particular institution should be indicated using superscript.

The official English-language name of the institution should be used for the information block in English.

We recommend authors to register at https://orcid.org/ if they do not have an ORCID ID.

Indicate the author responsible for contacts (phone, email) (correspondence author).

The authors are those people whom the research group have identified as the main participants in the presented work, and who have agreed to take responsibility for their work. In addition to being responsible for his own part of the work, the author must be able to indicate which of his co-authors is responsible for other parts of the work.

The journal “Ateroscleroz” accepts the following criteria of authorship:

1. Substantial contribution to the conceptualisation and design of the research, data collection or data analysis and interpretation;

2. Preparation of the article or its critical revision in terms of meaningful intellectual content;

3. Final approval of the version of the article for publication.

People who are not authors of the article should not be included in the list of authors. The names of people who are not authors, but who provided other support, should be indicated in the “Acknowledgments” section.

3.2. Abstract (summary) in Russian and English:

It is printed on a specific page in a structured way:

a) the objective of research;

b) material and methods;

c) results;

d) conclusions.

The abstract size should be limited to 300 words. Its content is usually the only section of articles indexed in electronic databases.

Keywords.

Three to seven keywords reflecting the abstract content and facilitating indexing in search systems are provided.

Acknowledgments.

This section indicates all sources of research funding, as well as acknowledging people who participated in the work on the article, but are not its authors. Participation in the work on the article implies: recommendations for improving the research, providing space for research, departmental control, obtaining financial support, singular analyses, provision of reagents / patients / animals / other materials for research.

Conflict of interest.

Authors should disclose potential and explicit conflicts of interest related to the manuscript. Any situation (financial relations, service or work in institutions having a financial or political interest in published materials, job duties, etc.) that could affect the author of the manuscript and lead to concealment, distortion of data, or change their interpretation can be considered a conflict of interests. The presence of a conflict of interest among one or more authors is not a reason for refusing to publish an article. The concealment of potential and obvious conflicts of interest on the part of the authors revealed by the editors may cause a refusal to consider and publish the manuscript.

If there is no conflict of interest, this must also be explicitly stated by the author(s). For example: “The authors declare no conflict of interest.”

3.3. Introduction of the article

Discloses the motivation of the study on the base of a literature survey and covers the state of the art with references to the most relevant publications. The goal, reflecting the urgency of the study, is formulated at the section end.

3.4. Material and methods

Provides information on the study objects (patients/examined persons) with qualitative and quantitative parameters or experimental animals, experimental design, and clinical, laboratory, instrumental, and other methods employed. A detailed description of the statistical methods of data processing should be provided. The manufacturer and country of origin should be indicated in parentheses on mentioning a device or pharmaceutical. International nonproprietrary names (INNs) of drugs are used in the Journal. Particular trademarks of drugs are indicated in the MATERIAL AND METHODS section with the indication of the INN and manufacturer. Example: Tarivid® (ofloxacin, Hoechst Marion Roussel).

Compliance with ethical standards. To publish the results of the original work, it is necessary to indicate whether the study participants signed the informed consent. In the case of studies involving animals - whether the research protocol was in accordance with the ethical principles and standards for conducting biomedical studies involving animals. In both cases, it is necessary to indicate whether the research protocol was approved by the ethics committee (with the name of the organization, its location, protocol number and date of the committee meeting).

3.5. Results

The results should be presented in their logical order in the text. They may be illustrated with tables and figures. Each table and figure should be perfomed in Russian and English. The journal provides printing of black-and-white figures. Printing of color figures is available at an additional cost in accordance with the existing printing rate (requests should be sent to ateroscleroz@gmail.com).

Results should not be duplicated: the text should not reproduce all data from tables and images; rather, only the most important data are mentioned. Figures should not duplicate data presented in tables. Use of units of the International System SI is preferable.

Explanation of abbreviations and explanatory notes should be given below the table. 

3.6. Discussion

The section includes the interpretation of results and their significance with relevant references to works by other scientists. The section content should be clear and concise. Novel and important facets of the study reported should be accentuated and, if possible, compared with data obtained by other investigators. Data presented in Introduction and detailed data from Results should not be repeated. The limitations and practical significance of the study should be indicated. 

3.7. Conclusions

The section summarizes inferences made in the study and based on authors' results.

3.8. Supplementary information in Russian and English

Information on Conflict of interests. Authors should disclose potential and explicit conflicts of interest related to the manuscript. Any situation (financial relations, service or work in institutions having a financial or political interest in published materials, job duties, etc.) that could affect the author of the manuscript and lead to concealment, distortion of data, or change their interpretation can be considered a conflict of interests. The presence of a conflict of interest among one or more authors is not a reason for refusing to publish an article. The concealment of potential and obvious conflicts of interest on the part of the authors revealed by the editors may cause a refusal to consider and publish the manuscript.

If there is no conflict of interest, this must also be explicitly stated by the author(s). For example: “The authors declare no conflict of interest.”

Sponsorship information. It is necessary to indicate the source of funding for both scientific work and the publication process of the article (fund, commercial or state organization, private individual, etc.).

Acknowledgments. The authors can express gratitude to the people and organizations that contributed to the publication of the article in the journal, but who are not its authors.

3.9. References

This fragment of the article should be prepared in accordance with the “Uniform requirements for manuscripts submitted to biomedical journals” and GOST R 7.0.5.-2008.

Each source in the list of references forms a separate paragraph. References should be enumerated and listed in the order of appearance. References in the text body are indicated in Arabic numerals enclosed in square brackets. Use Index Medicus to find journal abbreviations.

The list of references does not include references to dissertations, abstracts; patents and other documented works; official documents, orders, federal laws, WHO documents; recommendations of the Ministry of Health posted on the website of the Ministry of Health; links to any site. If you need to mention - send in the endnote.

DOI should be specified for all articles and ISBN for books. 

All authors of each source should be indicated in the list of references.

In the list of used literature, the names and initials of the authors are indicated first, the names of foreign authors are given in the original transcription, the name of periodicals can be written in abbreviated form, it can be found in the list of abbreviations Index Medicus or MEDLINE.

Pay attention to the recommended punctuation of links. Between the name of the journal and the year of its publication, it is recommended to put a comma, after the year of publication - without a space, a semicolon, volume (number), colon, pages, without the designation "volume", "No.", "page". 

For Russian-language sources, it is necessary to give a description in English on a new line without a source number. The source language should be indicated: (In Russ.).

It is advisable to use the transliteration webpage (Choose the BSI system) to transliterate references. 

Examples:

Book: Warlow C., Dennis S., van Gijn J., Hankey G., Sandercock P., Bamford J., Wardlaw J. Stroke: a practical guide to management. 2nd ed.Malden,MA:Blackwell Science, 2001. P. 151. ISBN: 978-1405127660

Puzyrev V.P., Stepanov V.A. Pathological anatomy of the human genome. Novosibirsk: Nauka, 1997. P. 224. ISBN: 5-02-031442-0. (In Russ.)

Пузырев В.П., Степанов В.А. Патологическая анатомия генома человека. Новосибирск: Наука, 1997. С. 224. ISBN: 5-02-031442-0.

Chapter from the book: Kannel W.B. The Framingham experience. In: Coronary heart disease epidemiology. Eds. M. Marmot, P.Elliott. Oxford: Oxford Univ. Press, 1996. P. 67–82. ISBN: 978-0192621245

Deev A.D., Shestov D.B. Lipids in population of Moscow and Leningrad In: Dyslipoproteinemia and coronary heart disease. Eds. E.I. Chazov, A.N. Klimov. Moscow: Meditsina, 1980. P. 168–178. (In Russ.)

Деев А.Д., Шестов Д.Б. Липиды в популяциях Москвы и Ленинграда. В кн.: Дислипопротеидемии и ишемическая болезнь сердца. Ред. Е.И. Чазов, А.Н. Климов. М.: Медицина, 1980. С. 168–178.

Article in collection: Evans A., Dobson A., Ferrario M., Kuulasmaa K., Moltchanov V., Sans S., Tunstall-Pedoe H., Tuomilehto J., Wedel H., Yarnell J., for the WHO MONICA Project. The WHO MONICA Project: changes in coronary risk in the 1980s. Proceedings of the XIth international Symposium on Atherosclerosis, 5–9 October 1997, Paris, France. Elsevier Science. Atherosclerosis XI, 1998, 49–55.

Article in journal: Igonina N.A., Zhuravleva E.A., Kondrasheva E.A., Torshina I.G., Chashchikhina E.V., Makarova T.A., Kopaeva L.B., Sysoeva S.N. The cholesterol level in Russian adults aged 20-70 years. Ateroskleroz i dislipidemii. 2012; 4: 67–71.(In Russ.)

Игонина Н.А., Журавлева Е.А., Кондрашева Е.А., Торшина И.Г., Чащихина Е.В., Макарова Т.А., Копаева Л.Б., Сысоева С.Н. Уровень холестерина в популяции взрослого населения РФ 20–70 лет. Атеросклероз и дислипидемии. 2012; 4: 67–71.

Rosenhek R., Binder T., Porenta G., Lang I., Christ G., Schemper M., Vaurer G., Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000; 343: 611-617. DOI: 10.1056/NEJM200008313430903

Cerezo A., Costan G., Gonzale A., Galvez C., Garcia V., Iglesias E., Reye A., de Dios J.F. Severe esophagitis due to overdose of iron tablets. Gastroenterol Hepatol. 2008; 31(8): 551-2. DOI: 10.1157/13127107

The editors reserve the right to reduce and correct accepted work. Manuscripts that are not written according to the rules are not considered. The royalty is not paid. Manuscripts are not returned to the authors.

The publication of articles in the journal "Ateroscleroz" is free. Printing of color figures is available at an additional cost in accordance with the existing printing rate (requests should be sent to ateroscleroz@gmail.com).

4. Systematic review and systematic review with meta-analysis

The editorial board of the journal "Ateroscleroz" supports the definition of a scientific review as an important part of the scientific knowledge. Accordingly, the methodology for creating review articles for the journal "Ateroscleroz" must comply with the principles and standards adopted in leading medical journals. 
Due to the fact that the journal "Ateroscleroz" strives to provide readers with materials of the highest quality and scientific significance, the editorial board will give preference to reviews in the form of systematic analyzes.
When writing systematic reviews, unlike descriptive literature reviews, a methodology is used that can significantly reduce the likelihood of erroneous conclusions due to incomplete information. Systematic review refers to the application of strategies that limit bias in the collection, critical appraisal, and synthesis of research on a particular topic. A systematic review may include a quantitative synthesis of the results of individual peer studies using meta-analysis. A systematic review usually answers a specific clinical question, for the answer to which literature sources are searched and selected according to clear criteria.
Thus, a review submitted to the journal "Ateroscleroz" must comply with the following rules:
• The review should be structured
• The urgency of the problem should be reflected
• The purpose of the review should be clearly stated.
• Methods of collecting information should be indicated: platforms, sites, total number of viewed works; keywords, authors, etc., for which the sample was made, are presented.
• The main part of the review should present the essence of the found works, and reflect the contradictions of the authors who hold different views on the problem under discussion.
• The discussion should include the opinion of the author of the review, coinciding or not coinciding with the opinion of the authors of the works cited in the review. It is also possible to evaluate the adequacy of the statistical methods used and to give a critical assessment of the works under discussion.
• The review should end with conclusions summarizing existing knowledge gaps and identify directions for future research.
• The review must be free of any bias, and the authors of the review must disclose any conflicts of interest.

5. Submission procedure

Please submit the manuscript via the online form available at the Journal webpage. The manuscript should be presented as a Microsoft Office Word document in the *.doc, *.docx, or *.rtf formats. The main file should not contain the names of authors and names of institutions. The text is printed on A4, spacing 1.5, margin 20 mm, basic font Times New Roman, 12 pt.

Additionally uploaded:

- a scan of cover letter from the institution where the study was performed;

- a scan of extract from the Ethics Committee meeting;

- an Information file with the Title page, information about the authors and disclosure of conflicts of interest;

- files with pictures if necessary;

- the license agreement filled and subscribed by the authorized author. The agreement should be uploaded in the *.pdf or *.jpg format.

6. Interaction between the Journal and the author

The editorial staff of the journal will correspond with the responsible (corresponding) author; however, if the authors wish, emails can be copied to all authors for whom an e-mail address is indicated.

All articles submitted to the journal “Ateroscleroz” are preliminarily checked by the executive secretary of the journal for their compliance with formal requirements. At this stage, the article can be returned to the author(s) for revision with a request to eliminate errors or add missing data. The article may be rejected due to its inconsistency with the purposes of the journal, lack of originality or low scientific value.

Following the preliminary check, the responsible editor submits the article to the reviewers, specifying the timing of the review.

In borderline cases, the editor may involve several more specialists in the review process, as well as the editor-in-chief.

With a positive conclusion of reviewers, the article is transferred to the editor for the preparation for the press.

When making a decision on the completion of an article, the comments and remarks of the reviewer are transmitted to the author. The author is given six months to resolve issues raised in comments. If, during this period, the author has not notified the editorial board about the planned actions, the article will be removed from the publication queue.

Should a decision be taken to refuse publication of an article, the appropriate decision will be sent to the corresponding author. Rejection rate of the journal “Ateroscleroz” is 20%.

The final (authoritative) version of the layout is sent to the corresponding author of the article accepted for publication, who is obliged to verify it. A response is expected from the authors within a period of two days. If no response will be received from the author, the article is considered to have been approved.

7. Procedure for reviewing the decisions of the editor / reviewer

If the author does not agree with the opinion of the reviewer and / or individual comments, he or she has the right to challenge the decision. In order to do this, the author must:

- correct the manuscript of the article according to the justified comments of reviewers and editors;

- clearly state his or her position regarding the issue under consideration.

The editors will facilitate the re-submission of manuscripts that could potentially be accepted, but have been rejected due to the need to make significant changes or to collect additional data; the editors are ready to explain in detail what needs to be corrected in the manuscript in order for it to be accepted for publication.

8. Editorial actions in case of detection of plagiarism, fabrication or falsification of data

In case of detection of scientific misconduct, i.e. plagiarism, fabrication or falsification of data on the part of the author, the editors are guided by COPE rules.

By “misconduct”, Journal “Ateroscleroz” refers to any actions taken by individual scientists, including improper handling of objects of study or intentional manipulation of scientific information whereby it ceases to reflect the observed studies, as well as scientific behaviour that does not correspond to accepted ethical and scientific standards.

However, the journal “Ateroscleroz” does not include under the term “misconduct” honest errors or discrepancies that have arisen during the process of carrying out, interpreting or evaluating research methods or results.

9. Correction of errors and recalling of articles

If errors are found in the text that affect its perception but do not distort the stated results of the study, they can be corrected by replacing the pdf file of the article and pointing out the error in the article file and on the article page on the journal’s website.

If an error is found in the text that distorts the results of the research, or if plagiarism or misconduct is detected on the part of the author(s) that relates to the falsification and / or fabrication of data, the article can be withdrawn. Initiator of article reviews can include editorial staff, authors, organisations or private individuals.

A withdrawn article will be marked with the sign “Article withdrawn” and the article page will include information on the reason for recalling the article. Information about the recall of the articles will be sent to the databases in which the journal is indexed.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

1. The manuscripts are accepted if has not been published or submitted for publication elsewhere.

2. The materials should be prepared in a format OpenOffice, Microsoft Word, RTF, or World Perfect.

3. Internet links are provided as a complete URL. 

4. Text should be typed with an interval of one and a half line spacing, font Times New Roman, 12 pt; to highlight the accents it is recommended to use italics rather than underlining (except Internet links). All images, graphics and tables are placed within the text according to the meaning of the particular part of text  (and not at the end of the document).

5. Text should follow the stylistic and bibliography requirements as stated in  Regulations  located in the Part "About Us." 

6. Please, remove the authors' names from the title of the article and other parts of the document to ensure the  anonymity of reviewing.

Copyright Notice

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Privacy Statement

Specified when registering the names and addresses will be used solely for technical purposes of a contact with the Author or reviewers (editors) when preparing the article for publication. Private data will not be shared with other individuals and organizations.